Cargando…

CD169(+) macrophages orchestrate plasmacytoid dendritic cell arrest and retention for optimal priming in the bone marrow of malaria-infected mice

Plasmacytoid dendritic cells (pDCs) are the most potent producer of type I interferon (IFN), but how pDC is primed in vivo is poorly defined. Using a mouse model of severe malaria, we have previously established that upon priming by CD169(+) macrophages (MPs), pDC initiates type I IFN-I secretion in...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore-Fried, Jamie, Paul, Mahinder, Jing, Zhixin, Fooksman, David, Lauvau, Gregoire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648966/
https://www.ncbi.nlm.nih.gov/pubmed/36278864
http://dx.doi.org/10.7554/eLife.78873
Descripción
Sumario:Plasmacytoid dendritic cells (pDCs) are the most potent producer of type I interferon (IFN), but how pDC is primed in vivo is poorly defined. Using a mouse model of severe malaria, we have previously established that upon priming by CD169(+) macrophages (MPs), pDC initiates type I IFN-I secretion in the bone marrow (BM) of infected mice via cell-intrinsic TLR7 sensing and cell-extrinsic STING sensing. Herein we show that CD169(+) MP and TLR7 sensing are both required for pDC arrest during priming, suggesting CD169(+) MP are the source of TLR7 ligands. We establish that TLR7 sensing in pDC and chemotaxis are both required for pDC arrest and functional communication with CD169(+) MP in the BM. Lastly, we demonstrate that STING sensing in CD169(+) MP control pDC initiation of type I IFN production while also regulating pDC clustering and retention/egress from the BM. Collectively, these results link pDC acquisition of type I IFN-secreting capacity with changes in their motility, homing and interactions with CD169(+) MP during infection. Thus, targeting this cellular interaction may help modulate type I IFN to improve outcomes of microbial infections and autoimmune diseases.